Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2013
10/09/2013CN103340864A Palonosetron composition for injection
10/09/2013CN103340861A Rabeprazole sodium composition for injection
10/09/2013CN103340858A Dolasetron composition for injection
10/09/2013CN103340846A Arachidonic acid soft capsule and preparation method
10/09/2013CN103340845A 药物组合物 The pharmaceutical composition of
10/09/2013CN103340844A Application of gamatine in preparing drug resisting high PTH
10/09/2013CN103340823A Formulation of paeonol proniosomes and preparing method thereof
10/09/2013CN103340788A Radices sileris toner
10/09/2013CN103340767A Rose water concentrated liquor processing method
10/09/2013CN103340340A Immunity-improving health food
10/09/2013CN103340257A Tea composition with kidney tonifying, yang tonifying, wind dispelling and dampness eliminating effects and instant tea production method
10/09/2013CN102716099B Levocetirizine hydrochloride chewable tablet and preparation method thereof
10/09/2013CN102613564B Ginseng, cartialgenous and lucid ganoderma capsule and preparation method of ginseng, cartialgenous and lucid ganoderma capsule
10/09/2013CN102452916B New aromatic polyketones, extraction method and application thereof
10/09/2013CN102430082B Traditional Chinese medicine sachet and preparation method thereof
10/09/2013CN102061322B Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner
10/08/2013US8552196 Apoptosis signal-regulating kinase inhibitors
10/08/2013US8552145 Vaccine for modulating between T1 and T2 immune responses
10/08/2013US8552040 Isoxazoline compounds having MIF antagonist activity
10/08/2013US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/08/2013US8551992 Aminooxazole inhibitors of cyclin dependent kinases
10/08/2013US8551522 Sustained-release formulation
10/08/2013US8551516 Administration of non-oral androgenic steroids to women
10/08/2013US8551501 Chitin microparticles and their medical uses
10/08/2013CA2547459C Modulators of nik-siva complex formation for treating immune disorders
10/08/2013CA2536492C Process for producing cytotoxic lymphocytes
10/08/2013CA2238893C Il-13 receptor polypeptide
10/04/2013CA2811762A1 Vaccine composition
10/03/2013WO2013148689A1 Neuropeptide y treatment of autoimmune disease
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013148372A1 Methods for amelioration of autoimmune disease using stem cells transduced with t cell receptors from il-10 secreting t cells
10/03/2013WO2013148183A2 Compositions and methods for inhibiting drusen
10/03/2013WO2013148134A1 Methods for modulating cell-mediated immunity using human milk oligosaccharides
10/03/2013WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4)
10/03/2013WO2013147135A1 Controlled-release pharmaceutical composition
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013146992A1 Method for producing pluripotent stem cells derived from dental pulp
10/03/2013WO2013146969A1 Novel disubstituted cyclohexane derivative
10/03/2013WO2013146963A1 Heterocyclic compound
10/03/2013WO2013146754A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity
10/03/2013WO2013146319A1 Diabetes-inducible bacterium
10/03/2013WO2013144412A1 System for conveying antigenic molecules in recombinant polymers similar to elastin
10/03/2013WO2013143597A1 Demethylase enzymes inhibitors
10/03/2013US20130259901 Neuropeptide Y Treatment of Autoimmune Disease
10/03/2013US20130259889 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/03/2013US20130259886 Broadly protective influenza t-cell vaccine against diverse influenza a viruses
10/02/2013EP2644621A1 Apoptotic anti-IgE antibodies
10/02/2013EP2643462A1 Inhibitors of sp140 and their use in therapy
10/02/2013EP2643322A1 Salts and crystalline forms of an apoptosis-inducing agent
10/02/2013EP2643321A1 Imidazo [1,2-b]pyridazine and imidazo [4,5-b]pyridine derivatives as jak inhibitors
10/02/2013EP2643303A1 Modulators of s1p receptors
10/02/2013EP2643005A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
10/02/2013EP2643004A1 Oligosaccharide composition for treating skin diseases
10/02/2013EP2642999A1 Methods of treatment using selective bcl-2 inhibitors
10/02/2013EP2642978A2 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders
10/02/2013CN103339253A TOMM34 peptides and vaccines including the same
10/02/2013CN103339134A Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
10/02/2013CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
10/02/2013CN103338781A Compositions and methods of aloe polysaccharides
10/02/2013CN103333860A Cells producing antibody compositions
10/02/2013CN103333253A Nano antibody fusion protein, and preparation method and application thereof
10/02/2013CN103333246A Anti-EGFR tumor growth inhibitor, preparation method thereof and applications thereof
10/02/2013CN103333245A Anti-cell-acceptor and anti-tumor-growth drug molecule, preparation method thereof and applications thereof
10/02/2013CN103333208A Adefovir dipivoxil maleate and preparation method and composition thereof
10/02/2013CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof
10/02/2013CN103333095A Adipamide D-hydroxyproline derivative and application thereof as nucleic acid vaccine adjuvant
10/02/2013CN103330935A Application of fructose as vaccine adjuvant
10/02/2013CN103330862A Stomachic tea for patient care of gastroenterology department
10/02/2013CN103330851A Traditional Chinese medicine for treating idiopathic thrombocytopenic purpura
10/02/2013CN103330840A External unguent for treating burn and preparation method thereof
10/02/2013CN103330818A Fungus electuary and preparation method thereof
10/02/2013CN103330760A Medicament used for treating allergic purpura
10/02/2013CN103330741A Japanese pagodatree twig injection
10/02/2013CN103330731A Mustard seed extract, preparation method and application of extractive
10/02/2013CN103330720A Mixing stem cell injection and preparation method thereof
10/02/2013CN103330717A Pearl nucleus treatment liquid for freshwater nucleated pearl, application of pearl nucleus treatment liquid and treatment method of freshwater nucleated pearl
10/02/2013CN103330712A Application of Myriberine A in preparation of a medicine for treating rhinitis
10/02/2013CN103330710A Ramosetron composition for injection
10/02/2013CN103330709A Ondansetron composition for injection
10/02/2013CN103330686A Freeze-dried powder injection for injection of chick embryo polysaccharide and preparation method thereof
10/02/2013CN103330677A Factor permease of mask
10/02/2013CN103330194A Tea camellia seed oil and tea polyphenol soft capsule and preparation method thereof
10/02/2013CN102652760B Tumor preventing compound preparation for improving immunity, replenishing blood and resisting oxidation
10/02/2013CN101687867B Imidazoquinolines with immuno-modulating properties
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546400 1,3-Oxazole-4-carboxamides, 1,3-Thiazole-4-carboxamides, and 1,3-Imidazole-d-carboxamides as Inhibitors of cyclin Dependent kinases
10/01/2013US8546143 Compositions and methods for inhibiting expression of a target gene
10/01/2013US8546124 Generating preferential vector nucleotide sequences, obtaining nucleotide sequences, incubating with preferential exogenous nucleotide sequences, ligating, recovering nucleotide sequences
10/01/2013US8545843 Treatment of vasculitis
10/01/2013CA2737335C 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/01/2013CA2725329C Nanoemulsion vaccines
10/01/2013CA2633374C Amine compound and use thereof for medical purposes
10/01/2013CA2624909C Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
10/01/2013CA2582668C Nanoparticles comprising antigens and adjuvants, and immunogenic structures
10/01/2013CA2573245C Multivalent vla-4 antagonists comprising polymer moieties
10/01/2013CA2565568C Pyrimidines as plk inhibitors
10/01/2013CA2551008C Anti-cd40 antibody mutants
10/01/2013CA2433862C Molecular antigen array presenting amyloid beta
10/01/2013CA2424379C Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1172